A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients. This ...

For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...

In a 6 to 2 vote, the Oncologic Drug Advisory Committee determined that findings from the phase 3 AQUILA trial do support a ...

The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma ...

The pharmaceutical company said Tuesday the FDA's Oncologic Drugs Advisory Committee voted 6-2 in favor of Darzalex Faspro, or daratumumab and hyaluronidase-fihj, to treat adult patients with ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Blenrep combinations to treat adults with relapsed or ...

The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease. More than 6 million people in the United States and millions more around the world ...

FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease By Stephanie Brown HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) -- The first in vitro diagnostic device that uses ...